CompletedNot Applicable

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

China1,352 participantsStarted 2019-10-09

Plain-language summary

The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a) ≥ 18 years of age; * b) Patients with adnexal masses; * c) Sign the informed consent form; * d) Adnexal mass that requires excision; Exclusion Criteria: * a) history of chemoradiotherapy; * b) history of malignancy; * c) pregnancy; * d) Adnexal mass not require surgical excision; * e) The adnexal mass has been diagnosed as malignant before surgery, and the number of cases enrolled in a single institution exceeds 50; * f) Blood CA125 value greater than 1000 U/ml at initial treatment.

What they're measuring

the Performance of Discrimination of Benign Disease and Malignant tumors by the OCS Value.

Timeframe: Data analysis would be completed in three months after all data were collected.

Trial details

NCT IDNCT06366997

SponsorChongqing University Cancer Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-18

View on ClinicalTrials.gov More Epithelial Ovarian Cancer trials